DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactStocks

NSE Stock Set for Additional Listing on Metropolitan Stock Exchange of India Starting September 24

NiftyTrader 4 hrs ago·23 Sept 2026, 12:10 pm

The National Stock Exchange (NSE) is expanding its reach by listing its shares on the Metropolitan Stock Exchange of India (MSEI). This dual listing will begin on September 24, allowing investors to trade the NSE stock on an additional exchange platform.

This move is significant for investors as it increases the liquidity and accessibility of the NSE stock. Having a presence on a second exchange provides more trading avenues and can potentially improve the stock's visibility among a broader set of market participants.

Investors should monitor the trading volumes and price movements on the MSEI platform. A successful dual listing often boosts investor confidence, but it is important to watch how the stock performs across both exchanges to gauge market sentiment.